Key takeaways
The most common side effects of Mounjaro are GI-related and include nausea, vomiting, constipation, and diarrhea.
Most side effects should improve within four to eight weeks of starting Mounjaro or increasing your dose.
Serious side effects of Mounjaro include severe stomach problems, an inflamed pancreas, low blood sugar, and thyroid cancer.
Mounjaro (tirzepatide) is approved by the U.S. Food and Drug Administration (FDA) for adults 18 years and older to treat Type 2 diabetes mellitus as an adjunct to diet and exercise. Mounjaro is a prescription-only injectable drug in a class of medicines known as GIP/GLP-1 receptor agonists. The following information highlights potential Mounjaro side effects and how to avoid them.
What are the most common side effects of Mounjaro?
The most common side effects of Mounjaro are gastrointestinal (GI) related and are generally mild to moderate. These include:
- Nausea
- Diarrhea
- Decreased appetite
- Vomiting
- Constipation
- Indigestion
- Stomach pain
- Burping
- Gastroesophageal reflux disease (GERD)
In clinical trials, most nausea, vomiting, and diarrhea events occurred during the first weeks of treatment or during dose increases. What you experience at 2.5 mg may differ significantly from what happens at 10 mg or 15 mg. These side effects tend to decrease over time, as your body adjusts to the medicine.
RELATED: Mounjaro side effects by dose
Mounjaro side effects statistics |
|||
|---|---|---|---|
| Side effect | How common | When it peaks | When it should improve |
| Nausea | Very common (12%-18%) | First 1-2 weeks at each new dose | Within 4-8 weeks at a stable dose |
| Diarrhea | Common (12%-17%) | Early in treatment or at higher doses | Usually within a few weeks |
| Constipation | Common (6%-7%) | Can persist at any dose level | Variable; may require dietary management |
| Vomiting | Common (5%-9%) | First 2-4 weeks at a new dose | Typically improves as body adjusts |
| Stomach pain or cramping | Common (5%-8%) | Peaks at dose increases | Often resolves within a few weeks |
| Fatigue | Reported | Varies by individual | Variable; may persist |
| Injection site reactions (redness, itching) | Common | After each injection | Usually resolves within 1-2 days |
| Hair thinning | Less common; associated with rapid weight loss | Typically 3-6 months into treatment | Often reverses as weight stabilizes |
Why does Mounjaro cause these side effects?
Tirzepatide, Mounjaro’s active ingredient, is a dual agonist: it simultaneously activates both the GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual action is what makes Mounjaro more potent than single GLP-1 agonists like semaglutide. It’s also why the GI adjustment period can be more pronounced.
Key mechanisms behind the most common symptoms:
- Slowed gastric emptying: GLP-1 receptor activation significantly slows how quickly food moves out of the stomach. This reduces appetite and calorie absorption, but it also causes nausea, bloating, indigestion, heartburn, belching, and stomach discomfort, especially after larger meals.
- Central nervous system effects: GLP-1 receptors in the brain directly influence nausea signals, independent of what is happening in the stomach. This is why some people feel nauseous even when they haven’t eaten.
- Dose escalation triggers re-adaptation: Every dose increase is a new physiological adjustment. Side effects that improved at 2.5 mg may briefly return at 5 mg, then settle again.
RELATED: Why do you have to increase your Mounjaro dose?
Who do Mounjaro side effects affect most?
According to research, women appear to be at slightly increased risk for gastrointestinal side effects (nausea, bloating, constipation, and diarrhea) compared with men. The reasons for this are not completely understood, but may be due to hormone levels, higher baseline rates of GI symptoms, and greater sensitivity to medications in general.
Diabetics (both men and women) may be more prone to GI side effects as compared to non-diabetics. This is in part due to alterations in gastrointestinal motility (how the GI tract contracts and moves) seen with diabetics, especially delayed stomach emptying. Patients with known gastroparesis (slow stomach emptying) and IBS should take greater care with starting Mounjaro, as they are more likely to experience GI side effects. If you have any of these conditions, make sure to have a discussion with your doctor about whether it is safe for you to start Mounjaro.
Mounjaro is only approved for use in adults and should not be used with any of the following conditions:
- Personal or family history of medullary thyroid carcinoma (MTC)
- History of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
- Allergy to any ingredients in Mounjaro
There is limited data regarding the use of Mounjaro in pregnant or breastfeeding women. A woman’s healthcare provider is the best source of medical advice when managing Mounjaro and other diabetes treatments while pregnant or breastfeeding. If you are using Mounjaro and find out that you are pregnant, notify your healthcare provider right away.
Serious side effects of Mounjaro: When to seek care
While most people who experience GI symptoms from Mounjaro find them manageable, Mounjaro does carry warnings for rare but serious complications. Early recognition matters, particularly for pancreatitis, where delays in care significantly affect outcomes.
Serious Mounjaro side effects and when to act |
||
|---|---|---|
| Condition | Symptoms to watch for | What to do |
| Pancreatitis | Severe, persistent abdominal pain that may radiate to the back; worsens after eating; may be accompanied by vomiting | Stop Mounjaro and seek emergency care immediately |
| Gallbladder disease | Severe upper-right abdominal pain, fever, nausea, jaundice (yellowing of skin or eyes) | Seek urgent medical care |
| Thyroid tumors (FDA boxed warning) | Lump or swelling in the neck, hoarseness, difficulty swallowing, shortness of breath | Contact your prescriber promptly. Do not use Mounjaro if you have a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2. |
| Severe dehydration or kidney damage | Inability to keep fluids down, dizziness when standing, dark urine, significantly reduced urination | Seek medical care; IV fluids may be required |
| Severe allergic reaction | Hives, swelling of the face, lips, tongue, or throat, difficulty breathing | Call 911 or go to the emergency room immediately |
RELATED: Is Mounjaro safe?
How soon do Mounjaro side effects start?
Many of the most commonly experienced GI side effects occur within the first one to two weeks of starting Mounjaro: nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, and abdominal pain. These symptoms may worsen during the first few weeks or months, especially when the dose is increased, but should begin to lessen once your body gets used to the medicine.
Hair thinning, if it occurs, typically starts three to six months into treatment and is generally related to the physiological stress of rapid weight loss (a condition called telogen effluvium), rather than to Mounjaro directly.
Less common, but more serious side effects, such as gallbladder problems or pancreatitis, may take months or years of drug use to occur.
RELATED: Mounjaro dosage guide
How long do Mounjaro side effects last?
Common GI side effects typically go away within four to eight weeks after starting Mounjaro, or following dose adjustments as the body has adjusted to the medicine.
Hair loss often reverses once weight loss slows or stabilizes.
Consult your healthcare provider if symptoms worsen over time or fail to improve after several weeks at the same dose. A slower dose escalation schedule can improve tolerability without affecting long-term outcomes.
More serious side effects, such as kidney problems or pancreatitis, will likely require the discontinuation of Mounjaro.
Managing side effects while your body adjusts |
||
|---|---|---|
| Side effect | Prevention | Additional resources |
| GI symptoms | Eat smaller, more frequent meals and avoid high-fat, greasy, or overly sweet foods | Mounjaro diet guide |
| Nausea, constipation, fatigue, kidney injury | Stay hydrated: sip water and electrolytes slowly throughout the day | Mounjaro nausea relief |
| Nighttime acid reflux | Avoid eating within 2-3 hours of bedtime to reduce nighttime acid reflux | What causes acid reflux at night? |
| Fatigue | Exercise regularly, increase protein intake, and get at least 7 hours of sleep each night | Does Mounjaro make you tired? |
| Injection site reactions | Routinely change the location of the injections | Mounjaro injection site reactions |
Ask your prescriber about a slower dose-escalation schedule if symptoms are significantly affecting your daily life. Staying at a lower dose longer is often preferable to stopping entirely.
RELATED: Best time of day to take Mounjaro
What are the long-term side effects of Mounjaro?
Tirzepatide received FDA approval in 2022, so long-term data extending beyond three to five years remains limited. Current evidence suggests that for most people who continue treatment, acute GI side effects improve over time.
Longer-term concerns supported by existing evidence include increased gallstone risk (a combined effect of GLP-1 activity and rapid weight loss), potential kidney effects from recurring dehydration episodes, and muscle mass loss with sustained caloric restriction.
While there have been reports of worsening diabetic retinopathy with the use of Mounjaro, this appears to be related to rapid improvements in blood sugar levels when starting this medication. Longer term studies show that Mounjaro is likely beneficial for diabetic retinopathy.
Full evidence-based breakdown: Mounjaro long-term side effects
What should you not take with Mounjaro?
Mounjaro can affect the efficacy of certain medications, and side effects can worsen if taken with certain medications or foods.
Birth control and thyroid meds: Because Mounjaro slows gastric emptying, it can alter how quickly other oral medications are absorbed and their effectiveness. People taking time-sensitive medications (including oral contraceptives, thyroid drugs, or anything with a narrow therapeutic window) should discuss medication timing adjustments with their prescriber.
Insulin and diabetes medications: The most clinically significant interaction is with insulin and other blood sugar-lowering medications, where Mounjaro’s glucose-lowering effect increases hypoglycemia risk substantially. People with Type 2 diabetes who take other diabetes medications are at higher risk for low blood sugar. If you experience hypoglycemia, eat or drink something high in sugar, such as a non-diet soda, fruit juice, or hard candy. Your healthcare provider may prescribe a glucagon injection or nasal spray for severe hypoglycemia.
RELATED: Mounjaro and metformin
Other weight loss meds: Combining a stimulant weight-loss medication, like phentermine, with a GLP-1 agonist raises cardiovascular safety questions.
Food interactions: Alcohol worsens nausea, dehydration, and blood sugar instability. Caffeine may aggravate GI symptoms, particularly at higher doses or when combined with a large meal.
Complete interactions reference: Mounjaro drug interactions
What happens when you stop taking Mounjaro?
When people discontinue Mounjaro, the medication’s effects reverse relatively quickly. Appetite suppression and slowed gastric emptying typically ease within weeks of stopping.
For people who have achieved significant weight loss, eventual weight regain is common without continued lifestyle changes or an alternative treatment.
For people using Mounjaro to manage Type 2 diabetes, stopping affects blood sugar control meaningfully and should always be done with a prescribing provider’s guidance. GI side effects typically resolve within a few days, but may take several weeks to resolve.
If you are experiencing side effects with Mounjaro, many people wonder about simply switching to another GLP-1 medication. Unfortunately, while this may help some patients, all of the GLP-1 medications can cause similar side effects, as they all act via similar mechanisms. In addition, Mounjaro tends to be better tolerated than some of the other GLP-1s.
RELATED: Ozempic vs. Mounjaro side effects | Wegovy vs. Mounjaro side effects
Is Mounjaro worth it?
Mounjaro is expensive, and side effects can make people question whether to continue this medication. A free SingleCare coupon can substantially lower Mounjaro’s cost, even without insurance, and there are several other ways to save.
Save up to 80% on Mounjaro with SingleCare Different pharmacies offer different prices for the same medication. SingleCare helps find the best price for you.
Expert takeaway
“As a board-certified gastroenterologist, I frequently see patients for GI-related side effects of Mounjaro and other GLP-1 medications,” says Jesse P. Houghton, MD, Senior Medical Director of Gastroenterology at Southern Ohio Medical Center. “My advice for patients is to start these medications at a low dose and increase their dose very gradually toward the goal. If significant side effects develop at any particular dose, don’t force the subsequent dose increase, but rather stay at the present dose, while focusing more on diet and lifestyle changes to achieve your weight loss and blood sugar goals.”
Lea este artículo en español aquí.
- Mounjaro, DailyMed (2025)
- Mounjaro consumer website, Eli Lilly and Co.
- Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the SURPASS clinical trials, Diabetes, Obesity and Metabolism (2024)
- Tirzepatide once weekly for the treatment of obesity, New England Journal of Medicine (2022)
- Anaphylactic reactions, Merck Manual (2024)
- Medically accurate: SingleCare’s Medical Review Board analyzes all of our content to confirm it’s in line with current medical advice.
- Evidence-based: Our content is sourced from reputable U.S.-based healthcare professionals and peer-reviewed research.
- Trustworthy: All of SingleCare’s content goes through a multi-phase review process by our writers, editors, and Medical Board in order to provide clear and credible information.